Text här 1

How can we accelerate the adoption of healthcare innovations while strengthening Sweden’s competitiveness in life science? These are key questions driving the strategic alliance between Medicon Village, AstraZeneca, Skåne University Hospital and Lund University School of Economics and Management. On 22–23 October, the partners gathered at Medicon Village to review …

Business leaders and representatives from the City of Lund and Lund University gathered last Wednesday to discuss how to strengthen Lund’s position as an international innovation hub and unlock the full potential of Lund Innovation District. The discussions focused on how to foster closer collaboration between …

SKÅNESTOR has been based in The Spark at Medicon Village since it was founded in 2022. The company provides specialist staffing and recruitment services in Skåne for life science, food and other regulated industries. Its journey at Medicon Village began with a flexible desk, followed a year later by a …

The board of KI Innovation visited Medicon Village last Tuesday for discussions on how to strengthen Sweden’s life science innovation ecosystem and create better conditions for translating research into innovations that benefit patients and society. The visit brought together representatives from Medicon Village Innovation, SmiLe Venture Hub, LU Innovation and …

Two years ago, we became part of something bigger. At first, the change was mostly visible on paper — a new owner and later a new name: Aurevia. Built on a strong foundation Our reputation has always been built on close relationships, deep expertise, and a clear focus on delivering …

Tissue-friendly electrodes, developed by researchers at Lund University in Sweden, are now undergoing clinical trials at Skåne University Hospital. Using 30 electrodes, each thinner than a strand of hair, the researchers aim to investigate the possibility of more precise stimulation and mapping of the brain prior to deep brain stimulation …

Xinnate, a clinical-stage biotech company at MV, is dedicated to developing TCP-25 as an innovative treatment for Epidermolysis Bullosa (EB). We are taking part in EB Awareness Week (October 25–30) to raise awareness of this serious condition. Meet us at the Meet & Greet at Inspira on Wednesday, October 28, …

How do you ensure innovation keeps pace with regulation? AI, software as a medical device, lifecycle management, post-market monitoring, clinical evidence, and real-world testing are no longer niche topics. They are central to the future of health technology. The Developing Health Technology track at the Medtech Compliance Forum by Aurevia …

Suturion AB has entered into an investment agreement with Cradle Growth AB. Cradle Growth is a newly established Nordic growth equity and venture capital firm focused on investing in healthcare and life science companies in the early commercial stage. The investment amounts to SEK 20 million and is being made …

Aurevia is a European Contract Research Organization (CRO) and regulatory partner supporting biotech, pharmaceutical, and medtech companies in the development and execution of oncology clinical research across Europe and beyond. Oncology clinical trials are complex—scientifically, operationally, and from a regulatory perspective. Our teams have deep knowledge with hands‑on experience, supporting …

Entering the UK market requires more than just registration—it requires the right regulatory partner. If you’re a non-UK manufacturer, appointing a UK Responsible Person (UKRP) is mandatory for placing medical devices on the UK market. At Aurevia, we provide end-to-end UKRP support to simplify your compliance journey: Acting as your …

In 2027, we will build on the great response to our “Life Science-dagen” and “Skånes Innovationsarena” at Almedalsveckan 2026 by expanding the former to three days, from Tuesday to Thursday, meeting demand from partners and attendees and strengthening our arena as a natural and attractive meeting place for life science.